Full Coverage

Aggressive lipid-lowering benefits bypass patients

reuters.com
May 21, 2008
        
Story Timeline:  197 days

NEW YORK (Reuters Health) - In patients who have had heart bypass surgery, taking the cholesterol-lowering drug Lipitor at a dose of 80 milligrams per day, rather than 10 milligrams per day, can markedly improve outcomes, new research shows. Major heart-related "events" fell by 27 percent and the... [read full story]                    

Add Comment
Latest article on this story:

New Analysis Showed That High Dose Lipitor Can Reduce The Risk Of Cardiovascular Events In Bypass...

 medicalnewstoday.com May 23, 2008
First article on this story:

New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass...

 businesswire.com May 21, 2008
Selected publications with coverage of this story:
redorbit.com pharmaceutical-business-review.com reuters.com reutershealth.com medicalnewstoday.com yahoo.com drugs.com pharmiweb.co.uk businesswire.com
RELATED
Found 8 documents:
                   

New Analysis Showed That High Dose Lipitor Can Reduce The Risk Of Cardiovascular Events In Bypass...

medicalnewstoday.com
May 23, 2008
        

Pfizer Inc announced that Lipitor® (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 percent in patients with heart disease who had previous coronary bypass surgery compared with patients taking the 10 mg dose of...

Pfizer's Lipitor reduces cardiovascular risks in bypass surgery patients

pharmaceutical-business-review.com
May 23, 2008
        

Pfizer has announced that Lipitor 80mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27% in patients with heart disease who had previous coronary bypass surgery compared with patients taking the 10mg dose of Lipitor.

Pfizer's Lipitor Reduces Cardiovascular Risks in Bypass Surgery Patients

redorbit.com
May 22, 2008
        

Pfizer has announced that Lipitor 80mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27% in patients with heart disease who had previous coronary bypass surgery compared with patients taking the 10mg dose of Lipitor.

                   

New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass...

drugs.com
May 22, 2008
        

NEW YORK--(BUSINESS WIRE)--May 21, 2008 - Pfizer Inc announced today that Lipitor(R) (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 percent in patients with heart...

Aggressive lipid-lowering benefits bypass patients

reutershealth.com
May 21, 2008
        

NEW YORK (Reuters Health) - In patients who have had heart bypass surgery, taking the cholesterol-lowering drug Lipitor at a dose of 80 milligrams per day, rather than 10 milligrams per day, can markedly improve outcomes, new research shows. Major heart-related "events" fell by 27 percent and the...

                   

New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass...

redorbit.com
May 21, 2008
        

Pfizer Inc announced today that Lipitor(R) (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 percent in patients with heart disease who had previous coronary bypass surgery compared with patients taking the 10 mg...

                   

New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass...

yahoo.com
May 21, 2008
        

NEW YORK----Pfizer Inc announced today that Lipitor® 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 percent in patients with heart disease who had previous coronary bypass surgery compared with patients taking the 10 mg dose of Lipitor.

                   

New Analysis Showed That High Dose Lipitor Can Reduce the Risk of Cardiovascular Events in Bypass...

businesswire.com
May 21, 2008
        

NEW YORK-- --Pfizer Inc announced today that Lipitor® (atorvastatin calcium) 80 mg significantly reduced the risk of major cardiovascular events, including heart attack and stroke, by 27 percent in patients with heart disease who had previous coronary bypass surgery compared with patients taking...